Lack of coordination among government bodies, coupled with a disruption in supply from China, had hit the Covid vaccine supply in Pakistan.
Officials in the federal government said that the task of procuring the vaccines had been assigned to the National Disaster Management Authority (NDMA) while the National Health Ministry was relieved of this duty. As a result, a lack of coordination was witnessed while there was a disruption in vaccine supplies from China which led to the crisis, Geo tv reported.
The NDMA, officials said, was not only dealing with Chinese vaccine manufacturers, including Sinopharm, Sinovac, and CansinoBIO, but it was also negotiating with Pfizer for the procurement of its mRNA vaccine for the country, a deal which could not be struck yet.
The officials added that Pakistan was relying heavily on the National Institute of Health (NIH) in Islamabad for the preparation and filing of single-dose Chinese vaccine Cansino from the bulk concentrate, which is being distributed in the name of PakVac, but the NIH also failed to fulfill its commitment of sustained supply of the single-dose vaccine.
“NIH Islamabad had assured that they would be providing three million doses of PakVac (Cansino) vaccine per month but it failed to meet its commitment”, officials added.
